Kodera Y - Search Results

1

Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas.

Sahin TT, Fujii T, Kanda M, Nagai S, Kodera Y, Kanzaki A, Yamamura K, Sugimoto H, Kasuya H, Nomoto S, Takeda S, Morita S, Nakao A. Sahin TT, et al. Among authors: kodera y. Pancreas. 2011 Oct;40(7):1029-33. doi: 10.1097/MPA.0b013e3182207893. Pancreas. 2011. PMID: 21705947

2

[Large volume intraperitoneal chemotherapy as treatment for the peritoneal carcinomatosis from gastric cancer].

Yamauchi M, Ito A, Kodera Y, Kondo K, Nakahara H, Nagai S, Kuzuya T, Satta T, Ito K, Takagi H. Yamauchi M, et al. Among authors: kodera y. Gan To Kagaku Ryoho. 1992 Apr;19(4):463-8. Gan To Kagaku Ryoho. 1992. PMID: 1558395 Japanese.

3

Establishment and characterization of human gastric and colonic xenograft lines resistant to CPT-11 (a new derivative of camptothecin).

Nagai S, Yamauchi M, Andoh T, Nishizawa M, Satta T, Kodera Y, Kondou K, Akiyama S, Ito K, Takagi H. Nagai S, et al. Among authors: kodera y. J Surg Oncol. 1995 Jun;59(2):116-24. doi: 10.1002/jso.2930590209. J Surg Oncol. 1995. PMID: 7776652

4

Growth inhibition of human gastrointestinal cancer xenograft lines by treatment with CPT-11 and VP-16.

Nagai S, Yamauchi M, Satta T, Kodera Y, Kondou K, Akiyaya S, Ito K, Takagi H. Nagai S, et al. Among authors: kodera y. J Surg Oncol. 1993 Dec;54(4):211-5. doi: 10.1002/jso.2930540404. J Surg Oncol. 1993. PMID: 8255079

5

Gastric remnant carcinoma after partial gastrectomy for benign and malignant gastric lesions.

Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. Kodera Y, et al. J Am Coll Surg. 1996 Jan;182(1):1-6. J Am Coll Surg. 1996. PMID: 8542082

6

The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer.

Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. Kodera Y, et al. Am J Gastroenterol. 1996 Jan;91(1):49-53. Am J Gastroenterol. 1996. PMID: 8561143

7

Surgical treatment of Borrmann type IV gastric carcinoma: relevance of lymphadenectomy in improving survival.

Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. Kodera Y, et al. J Am Coll Surg. 1996 Nov;183(5):480-5. J Am Coll Surg. 1996. PMID: 8912617

8

Metastatic gastric lymph node rate is a significant prognostic factor for resectable stage IV stomach cancer.

Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. Kodera Y, et al. J Am Coll Surg. 1997 Jul;185(1):65-9. doi: 10.1016/s1072-7515(97)00006-9. J Am Coll Surg. 1997. PMID: 9208963

9

Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM Classification? Tumor Node Metastasis.

Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. Kodera Y, et al. J Surg Oncol. 1998 Sep;69(1):15-20. doi: 10.1002/(sici)1096-9098(199809)69:1<15::aid-jso4>3.0.co;2-n. J Surg Oncol. 1998. PMID: 9762886

10

The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification.

Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. Kodera Y, et al. J Am Coll Surg. 1998 Dec;187(6):597-603. doi: 10.1016/s1072-7515(98)00229-4. J Am Coll Surg. 1998. PMID: 9849732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,401 results

Search Page

Filters